Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

AIPD AI in Parkinson's Disease

Coordinator
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV, Germany
Runs
1 November 2024 to 31 October 2028
Status
Running
EU funding
€3.7m
Total cost
—
Partners
16 organisations in 9 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101168379

What the project is doing

In the project's own words, from its summary on CORDIS.

In response to the growing need for specialized data scientists in healthcare, our initiative aims to establish an international, interdisciplinary graduate school that educate the next generation of medical data scientists, with a strong translational focus bridging academia and industry. This is strengthened by the active involvement of leading global pharmaceutical and med-tech companies as well as SMEs in the AI field, thus ensuring that our research and training remain at the forefront of industry and healthcare.

We propose a comprehensive training program offering PhD students not only a robust foundation in data science, including AI/ML and digital health, but also a deep understanding of ethical, legal and regulatory frameworks, including GDPR, the European Health Data Space and the AI Act. Our curriculum is unique in its integration of entrepreneurial thinking and a focus on Parkinson’s disease (PD) as an application field.

At the same time, the methodologies and insights gained will have broader applications in various disorders, thus applicable to other areas of healthcare. We will move with our research program clearly beyond the state of the art by: - Developing new AI/ML models spanning the entire journey of a PD patient to support medical decision-making on a more individual basis,- Pioneering the use of recent causal AI/ML techniques in PD research,- Investigating the optimization of future clinical trials,- Providing novel insights into digital and neuroimaging markers,- Developing innovative algorithmic solutions to enhance the generalizability of AI/ML models,- Providing understanding of the ethical, legal and regulatory basis of the use of AI in medical practice.

All participants are highly committed to the research, teaching, supervision and management activities in this program, and this commitment is supported by existing working relationships through other projects, such as ERA PerMed DIGIPD, IHI PREDICTOM and IHI IDERHA.

Topics

Who is involved

OrganisationCityCountryRole
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyCoordinator
Universite De NamurNamurBelgiumParticipant
Ge Healthcare GmbHDusseldorfGermanyAssociatedpartner
Ki Elements GmbHSaarbruckenGermanyParticipant
Petanux GmbHBonnGermanyParticipant
Rheinische Friedrich-Wilhelms-Universitat BonnBonnGermanyAssociatedpartner
Technische Universitaet DresdenDresdenGermanyAssociatedpartner
Novo Nordisk A/sBagsvaerdDenmarkAssociatedpartner
Universidad De NavarraPamplonaSpainAssociatedpartner
Institut Du Cerveau Et De La Moelle EpiniereParisFranceAssociatedpartner
Royal College of Surgeons in IrelandDublin 2IrelandParticipant
Universita Di PisaPisaItalyParticipant
Centre Hospitalier De LuxembourgLuxembourgLuxembourgAssociatedpartner
Luxembourg Institute of HealthStrassenLuxembourgParticipant
Universite Du LuxembourgEsch-Sur-AlzetteLuxembourgParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI